Plasmonic Nanotags for On‐Dose Authentication of Medical Tablets
Source abstract
Abstract
Abstract Plasmonic nanomaterials have attracted much attention to new anticounterfeiting technology. Since one of current anticounterfeiting problems is fake medical tablets, on‐dose authentication of the tablets is strongly required considering tiny area of tablets, biocompatibility, and long shelf life. Previously, Nanotags consisting of self‐assemblies of colloidal gold nanoparticles with reporter molecules were proposed, which produce characteristic surface enhanced Raman scattering (SERS) activity. However, long‐term stability is rarely discussed for SERS active nanostructures. This study deposits about 10 ng of the Nanotags on a very tiny area of the commercial tablets. Distinguishable SERS signals of reporting molecules are confirmed by 1s irradiation of 785 nm laser over the Nanotags, while Raman spectrum of the ingredients is observed on the tablet without the Nanotags. Rapid authentication of tablets stocked over 8 years is sufficiently carried out. In addition, the Nanotags on the tablets are almost invisible to the eye, in particular, if the tablet surface is uneven or colored. It is considered that the presence of discrete AuNP assemblies allows excellent performances of Nanotag.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications · Pharmaceutical Quality and Counterfeiting
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Micro Engineering Kyoto University Kyoto Daigaku‐Katsura, Nishikyo‐ku Kyoto 615–8540 Japan
Laboratory of Pharmaceutical Engineering School of Pharmacy Aichi Gakuin University 1–100 Kushumoto‐cho, Chikusa‐ku, Nagoya Aichi 464–8650 Japan
Laboratory of Advanced Science and Technology University of Hyogo 3‐1‐2 Kouto, Kamigori, Ako‐gun Hyogo 678–1205 Japan
Funding
New Energy and Industrial Technology Development Organization
References (75)
Show source-provided references
1. 10.1038/s41565-019-0484-010.1038/s41565-019-0484-0 ↗
2. OECD Trends in Trade in Counterfeit and Pirated Goods(accessed: March 2019).
3. 2017 · 383
4. Office of the United State Trade Representative Releases 2020 Review of Notorious Markets for Counterfeiting and Piracy https://ustr.gov/sites/default/files/files/Press/Releases/2020%20Review%20of%20Gotorious%20Markets%20for%20Counterfeiting%20and%20Piracy%20(final).pdf(accessed: January 2021).
5. INTERPOL. “Global operation sees a rise in fake medical products related to COVID‐19” https://www.interpol.int/News‐and‐Events/News/2020/Global‐operation‐sees‐a‐rise‐in‐fake‐medical‐products‐related‐to‐a‐rise‐in‐fake‐medical‐products‐related‐to‐COVID‐19(accessed: March 2020).
6. 10.1038/434132a10.1038/434132a ↗
7. 10.1021/acs.analchem.6b0026310.1021/acs.analchem.6b00263 ↗
8. 10.1038/nchem.145110.1038/nchem.1451 ↗
9. 10.1016/j.forsciint.2014.11.01510.1016/j.forsciint.2014.11.015 ↗
10. 10.3797/scipharm.1202-0310.3797/scipharm.1202-03 ↗
11. 10.1016/S1473-3099(06)70581-310.1016/S1473-3099(06)70581-3 ↗
12. 10.1021/acs.nanolett.9b0505310.1021/acs.nanolett.9b05053 ↗
13. 10.1002/adma.20190548610.1002/adma.201905486 ↗
14. 10.1002/adom.20160024710.1002/adom.201600247 ↗
15. 10.1021/acsomega.0c0520710.1021/acsomega.0c05207 ↗
16. 10.1021/acsami.6b0235910.1021/acsami.6b02359 ↗
17. 10.1021/acsnano.8b0134410.1021/acsnano.8b01344 ↗
18. 10.1038/s41570-017-003110.1038/s41570-017-0031 ↗
19. T.Fukuoka A.Yamaguchi R.Hara T.Matusmoto Y.Utsumi Y.Mori 2015 Int. Conf. on Electronics Packaing and iMPAS All Asia Conference (ICEP-IAAC 2015) Proc.2015 432‒435.10.1109/ICEP-IAAC.2015.7111051 ↗
20. 10.1038/s41598-022-04901-z10.1038/s41598-022-04901-z ↗
21. 10.1038/s41467-019-14070-910.1038/s41467-019-14070-9 ↗
22. 10.1248/yakushi.22-0014710.1248/yakushi.22-00147 ↗
23. 10.1016/j.ijpharm.2022.12198010.1016/j.ijpharm.2022.121980 ↗
24. 10.1002/adom.20220154910.1002/adom.202201549 ↗
25. 10.1038/srep0517010.1038/srep05170 ↗
26. 10.1002/adma.20060280010.1002/adma.200602800 ↗
27. 10.1038/s41467-019-14066-510.1038/s41467-019-14066-5 ↗
28. Yamaguchi A. · 2021
29. M. P.O'Neil P.Pearons T.Zhou T.Learmounth U. S. Patent US008881972B2 2014.
30. WuXi AppTec and TruTag Technologies Inc. On‐Dose Authentication: Stress Testing of Solid Oral Dossage Form Pharmaceuticals Coated with TruTag Silica Microtag https://trutags.com/wp‐content/uploads/2017/12/WuXi‐TruTag‐SODF‐White‐Paper_2016.11.14.pdf(accessed: May 2016).
31. 10.1021/acsami.8b1740310.1021/acsami.8b17403 ↗
32. 10.1088/0957-4484/25/15/15530310.1088/0957-4484/25/15/155303 ↗
33. 10.1002/adma.20140548310.1002/adma.201405483 ↗
34. 10.1021/acsnano.0c0897410.1021/acsnano.0c08974 ↗
35. 10.1039/C4CC08596E10.1039/C4CC08596E ↗
36. 10.1021/nl072606s10.1021/nl072606s ↗
37. 10.1002/adfm.20150398910.1002/adfm.201503989 ↗
38. 10.1016/j.proeng.2014.03.13510.1016/j.proeng.2014.03.135 ↗
39. 10.1002/adma.20120284510.1002/adma.201202845 ↗
40. 10.1021/nn101231u10.1021/nn101231u ↗
41. M. J.Natan S.Norton R.Freeman S.Penn I.Walton US Patent 2006/0038979A1 2007.
42. M. J.Natan R. D.Freeman W. E.Doering M. E.Piotti US Patent 2013/0009119A1 2015.
43. 10.1002/adma.20150502210.1002/adma.201505022 ↗
44. 10.1021/cr300120g10.1021/cr300120g ↗
45. M.Wall BBC News https://www.bbc.com/news/business‐37470667(accessed: September 2016)
46. U. S. Food and Drug Administration https://www.fda.gov/media/116720/download(accessed: October 2021)
47. 10.1111/tmi.1316110.1111/tmi.13161 ↗
48. 10.1021/ja00457a07110.1021/ja00457a071 ↗
49. 10.1039/f2979750079010.1039/f29797500790 ↗
50. 10.1016/S0022-0728(77)80224-610.1016/S0022-0728(77)80224-6 ↗
51. 10.1103/PhysRevLett.78.166710.1103/PhysRevLett.78.1667 ↗
52. 10.1143/JPSJ.52.385310.1143/JPSJ.52.3853 ↗
53. Itoh T. · Can. J. Anal. Sci. Spectrosc. · 2007 · 52 · 130
54. 10.1063/1.220514910.1063/1.2205149 ↗
55. 10.2116/analsci.23.82910.2116/analsci.23.829 ↗
56. 10.7567/JJAP.52.06GK1210.7567/JJAP.52.06GK12 ↗
57. 10.1039/C4RA09309G10.1039/C4RA09309G ↗
58. 10.1016/j.apsusc.2018.09.20610.1016/j.apsusc.2018.09.206 ↗
59. 10.1016/j.colsurfa.2016.07.09410.1016/j.colsurfa.2016.07.094 ↗
60. 10.1016/j.snb.2016.02.02310.1016/j.snb.2016.02.023 ↗
61. 10.1007/978-3-642-41395-7_310.1007/978-3-642-41395-7_3 ↗
62. 10.1109/JPROC.2014.232051610.1109/JPROC.2014.2320516 ↗
63. 10.1109/MITP.2019.294994410.1109/MITP.2019.2949944 ↗
64. 10.1109/HST.2013.658155610.1109/HST.2013.6581556 ↗
65. 10.1038/physci241020a010.1038/physci241020a0 ↗
66. 10.1016/j.vibspec.2003.12.00610.1016/j.vibspec.2003.12.006 ↗
67. 10.1016/j.molstruc.2017.05.07010.1016/j.molstruc.2017.05.070 ↗
68. 10.1136/bmjgh-2018-00072510.1136/bmjgh-2018-000725 ↗
69. 10.2147/IJN.S842810.2147/IJN.S8428 ↗
70. 10.3109/17435390.2011.55281110.3109/17435390.2011.552811 ↗
71. Sani A. · Biochem. Biophys. Rep. · 2021 · 21
72. 10.1186/1477-3155-8-3310.1186/1477-3155-8-33 ↗
73. 10.1093/rheumatology/36.5.56010.1093/rheumatology/36.5.560 ↗
74. 10.1155/2020/128164510.1155/2020/1281645 ↗
75. Society 5.0 https://www8.cao.go.jp/cstp/english/society5_0/index.html.